Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2021 Results Conference Call August 17, 2021 4:30 PM ET Company Participants Dr. George Zavoico - VP, IR & Corporate Development Dan Passeri - Chief Executive Officer Dr. Anish Suri - President & Chief Scientific Officer Dr. Ken Pienta - Acting Chief Medical Officer Dr. Matteo Levisetti - SVP, Clinical Development Kerri-Ann Millar - Chief Financial Officer Conference Call Participants Mark Breidenbach - Oppenheimer Stephen Wiley - Stifel Tom Shrader - BTIG Brian Skorney - ...